Patents by Inventor Christopher Carter

Christopher Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11111368
    Abstract: A continuous solution polymerization process is disclosed wherein at least two catalyst formulations are employed. A first homogeneous catalyst formulation is employed in a first reactor to produce a first ethylene interpolymer and a first heterogeneous catalyst formulation is employed in a second reactor to produce a second ethylene interpolymer. Optionally a third ethylene interpolymer is formed in a third reactor. The resulting ethylene interpolymer products possess desirable properties in a variety of end use applications, for example in film applications. A means for increasing the molecular weight of the first ethylene interpolymer is disclosed and/or a means for increasing the temperature of the first reactor, relative to a third homogeneous catalyst formulation. A means for reducing the (?-olefin/ethylene) weight ratio in the first reactor is disclosed and/or reducing the density of the first ethylene interpolymer, relative to a third homogeneous catalyst formulation.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: September 7, 2021
    Assignee: NOVA Chemicals (International) S.A.
    Inventors: Zengrong Zhang, Niousha Kazemi, Stephen Salomons, Monika Kleczek, Mehdi Keshtkar, Brian Molloy, Qinyan Wang, Peter Zoricak, Charles Carter, XiaoChuan Wang, Christopher Dobbin, Fazle Sibtain, Kenneth Taylor, Lawrence VanAsseldonk, Hamidreza Khakdaman
  • Patent number: 11114194
    Abstract: Networks and methods include receiving healthcare information and with a computer identifying when a patient is readmitted to a healthcare provider. A readmission notification is generated for identified readmissions. The notification may identify the patient being readmitted, the readmitting event, prior event(s) and provider(s), substantive healthcare and clinical status for the patient, treatment dates, and/or any other desired information. Readmission alerts can be formatted and provided in accordance with their consumers' parameters. Example methods and embodiments may receive, process, store, compare, and otherwise use any of HL7 messages, CCDA information, clinical feeds, or any other type of electronic healthcare record. This information may be received from any number of different healthcare information sources and providers.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: September 7, 2021
    Assignee: Audacious Inquiry
    Inventors: Sandeep Antony, Scott Afzal, Evan Carter, Christopher Brandt, Yedong Tang
  • Publication number: 20210233628
    Abstract: A method and system is disclosed for receiving patient test data from a point of care device for a medical test performed on a patient using the point of care device, performing device specific processing on the received patient test data by processing the received patient test data to identify a device type from the received patient test data, and reformatting the received patient test data according to a test type using the identified device type, and transmitting the reformatted patient test data to a remote server system over a network.
    Type: Application
    Filed: February 2, 2021
    Publication date: July 29, 2021
    Inventors: Nestor Rentas, Sheila Coffman, Gregg Flynn, Marryat Stevens, Steven Hall, Christopher Carter, Neil Farish
  • Patent number: 10930376
    Abstract: A method and system is disclosed for receiving patient test data from a point of care computer, identifying additional required data missing from the patient test data according to electronic health record provider requirements, transmitting an indication to the point of care computer of the additional required data to be input by an operator of the point of care computer; receiving operator input data from the operator; and adding the input data to the patient test data to store complete patient test data.
    Type: Grant
    Filed: August 19, 2014
    Date of Patent: February 23, 2021
    Assignee: Goodmark Medical (International) Limited
    Inventors: Nestor Rentas, Sheila Coffman, Gregg Flynn, Marryat Stevens, Steven Hall, Christopher Carter, Neil Farish
  • Publication number: 20200384306
    Abstract: An exercise device for assisting a user in performing bodyweight exercises as well as being configured for performance of weight training cable exercises includes a frame that is configured to be detachably mounted to a doorframe. The frame includes a first door bar and a second door bar that is spaced from the first door bar and is configured for contacting the doorframe on a first side of the doorframe. The exercise device also includes a pair of door hook assemblies that are coupled to the frame and are configured to seat against a ledge of the doorframe on a second side of the doorframe for securely yet detachably mounting the frame to the doorframe. A pulley carrier assembly is detachably coupled to both the first door bar and the second door bar and includes an elongated carrier that carries a first pulley and a spaced second pulley. A cable passes along the first pulley and the second pulley and the cable has a first end and an opposing second end.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 10, 2020
    Inventors: Thomas Christopher Carter, William Bottiglieri
  • Patent number: 10772550
    Abstract: The invention relates to analyte monitoring/drug (pharmaceutical agent) delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The electronics portion includes a processor and associated circuitry (e.g., memory, supporting electronics and the like), a motor or the like, a sensor, a power supply (e.g., battery) and optionally an interface. In general, the processor controls the operation of the device and is data communication with the actuator, motor, sensor and interface. The invention provides for autonomous operation, that is, without intervention of the user.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: September 15, 2020
    Assignee: Intuity Medical, Inc.
    Inventors: John Gregory Aceti, Sterling Eduard McBride, Richard Morgan Moroney, III, Christopher Carter Gregory, Peter John Zanzucchi
  • Patent number: 10753222
    Abstract: A gas turbine engine sealing system includes a case including forward and aft hooks. The aft hook arranged radially outward of the forward hook. A blade outer air seal has a J-hook that receives the aft hook and includes an end received by the forward hook.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: August 25, 2020
    Assignee: Raytheon Technologies Corporation
    Inventors: Jonathan Jeffery Eastwood, Joseph F. Englehart, Christopher Carter Venable, Michael G. McCaffrey
  • Publication number: 20200226540
    Abstract: A cryptographically enforced ordering and hierarchical ledger for the distributed collection and processing of inventory data across multiple locations, areas and items is provided.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 16, 2020
    Applicant: Omnicounts, LLC
    Inventor: Christopher Carter Graves
  • Patent number: 10555907
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: February 11, 2020
    Assignee: Santarus, Inc.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • Publication number: 20190231699
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Application
    Filed: August 31, 2018
    Publication date: August 1, 2019
    Applicant: Santarus, Inc.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • Publication number: 20190162625
    Abstract: A leak detection system including a sensor having a first state having a first condition when dry and a second condition when wet, and a second state adapted to monitor the operability of the sensor; a communication device operatively connected to the sensor; and an attachment element adapted to attach the leak detection system to a fluid component for monitoring fluid leakage.
    Type: Application
    Filed: November 26, 2018
    Publication date: May 30, 2019
    Inventors: Raymond Alan CARR, James Christopher Carter, St├ęphane Domy, Charles S. Golub, Julien Nallet, Hy B. Nguyen, Gerald H. Ling
  • Patent number: 10269107
    Abstract: A field image is formed using a tristimulus color model and used to detect target plants or entities on a field. Through the use of a luminance parameter floor, hue and saturation selection steps, feature recognition, a sizing floor and an aspect ratio ceiling, a very fast way is devised to recognize a target plant without need for consulting plant attribute databases, or to analyze spectral or other specialized data for comparison with known attributes. This allows a low calculational processing load and use of simple hardware such as a single board computer to handle machine vision in real time. Treatment steps can include a spray event, a light treatment, and a thermal/mechanical trauma.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: April 23, 2019
    Assignee: Global Neighbor Inc
    Inventors: Jonathan A Jackson, Norman Novotney, Christopher Carter, Austin Erdman, Patrick A Jackson
  • Publication number: 20190083366
    Abstract: The present invention relates to a dry mouthwash comprising granules that reconstitute in an aqueous solution, such as water, to produce a solution that tastes and functions as a typical liquid mouthwash.
    Type: Application
    Filed: September 19, 2017
    Publication date: March 21, 2019
    Inventors: Pratik SHAH, John Christopher CARTER
  • Publication number: 20190078457
    Abstract: A gas turbine engine sealing system includes a case including forward and aft hooks. The aft hook arranged radially outward of the forward hook. A blade outer air seal has a J-hook that receives the aft hook and includes an end received by the forward hook.
    Type: Application
    Filed: September 11, 2017
    Publication date: March 14, 2019
    Inventors: Jonathan Jeffery Eastwood, Joseph F. Englehart, Christopher Carter Venable, Michael G. McCaffrey
  • Patent number: 10071058
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention relates to a method of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowel disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: September 11, 2018
    Assignee: Santarus, Inc.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • Publication number: 20180240228
    Abstract: A field image is formed using a tristimulus color model and used to detect target plants or entities on a field. Through the use of a luminance parameter floor, hue and saturation selection steps, feature recognition, a sizing floor and an aspect ratio ceiling, a very fast way is devised to recognize a target plant without need for consulting plant attribute databases, or to analyze spectral or other specialized data for comparison with known attributes. This allows a low calculational processing load and use of simple hardware such as a single board computer to handle machine vision in real time. Treatment steps can include a spray event, a light treatment, and a thermal/mechanical trauma.
    Type: Application
    Filed: February 23, 2017
    Publication date: August 23, 2018
    Inventors: Jonathan A. JACKSON, Norman Novotney, Christopher Carter, Austin Erdman, Patrick A. Jackson
  • Publication number: 20170319121
    Abstract: The invention relates to analyte monitoring/drug (pharmaceutical agent) delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The electronics portion includes a processor and associated circuitry (e.g., memory, supporting electronics and the like), a motor or the like, a sensor, a power supply (e.g., battery) and optionally an interface. In general, the processor controls the operation of the device and is data communication with the actuator, motor, sensor and interface. The invention provides for autonomous operation, that is, without intervention of the user.
    Type: Application
    Filed: March 22, 2017
    Publication date: November 9, 2017
    Inventors: John Gregory ACETI, Sterling Eduard MCBRIDE, Richard Morgan MORONEY, III, Christopher Carter GREGORY, Peter John ZANZUCCHI
  • Patent number: 9808606
    Abstract: The present invention relates to a valve system for an inflatable portion of an indwelling medical device and more particularly to a valve system for fluid regulation of a catheter comprising a fluid inflatable portion that undergoes pressure changes within the body during use.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: November 7, 2017
    Assignee: CONVATEC TECHNOLOGIES INC.
    Inventors: Yun Jin, Christopher Carter Gregory
  • Publication number: 20170259046
    Abstract: The present invention relates to a valve system for an inflatable portion of an indwelling medical device and more particularly to a valve system for fluid regulation of a catheter comprising a fluid inflatable portion that undergoes pressure changes within the body during use.
    Type: Application
    Filed: June 19, 2015
    Publication date: September 14, 2017
    Inventors: Yun JIN, Christopher Carter GREGORY
  • Patent number: 9603562
    Abstract: The invention relates to analyte monitoring/drug delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The invention can optionally provide for calibration without intervention of the user and can also provide for semi-continuous monitoring for day and night time. The invention can provide up to four, or more, weeks of operation. The invention can provide for a device that is relatively small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: March 28, 2017
    Assignee: Intuity Medical, Inc.
    Inventors: John Gregory Aceti, Sterling Eduard McBride, Richard Morgan Moroney, III, Christopher Carter Gregory, Peter John Zanzucchi